Institutional news
IBEC contributes to multi-disciplinary efforts to understand the brain and improve neurological healthcare
The Group of Pau Gorostiza at IBEC participates in the “Emerging Cluster of the Human Brain! (CECH) RIS3CAT Initiative, in which research institutes and industry work together to achieve an integrative and multi-level understanding of the human brain.
The Edison of medicine visits IBEC
The Institute for Bioengineering of Catalonia (IBEC) invites Robert Langer, and other renowned international speakers, to its annual symposium to talk about how bioengineering can shape the future of precision medicine. Langer, Professor of the Technological Institute of Massachusetts (MIT), and Director of its biomedical engineering laboratory, is considered the father of intelligent drugs delivery, the most cited engineer in the world but, especially, a global pioneer with over thousand patents and promoter of dozens of companies with great projection, which has earned him the nickname of “The Edison of Medicine”.
An IBEC project on COVID-19 receives funding from “Fundación BBVA”
Nuria Montserrat and her research team at IBEC, receive funding from “Fundación BBVA” to lead a research project on COVID-19. Montserat’s project is one of the 20 projects selected from among almost 1,000 proposals submitted to the call, which will receive a total of 2.7 million euros. The twenty projects selected to stop the coronavirus outbreak involve more than 400 researchers, who will approach the mechanisms of infection, diagnosis and treatment of this disease from different angles. The psychosocial and economic impact derived from the pandemic will also be studied.
Nobel Prize for CRISPR/Cas9, one of sharpest bioengineering tools
Emmanuelle Charpentier and Jennifer Doudna have been awarded the Nobel Prize in Chemistry 2020 for discovering a gene technology in Bioengineering: the CRISPR/Cas9 genetic scissors. The announcement marks the first time a science Nobel has been awarded to two women.
IBEC supports the accessibility to EU funded research results on COVID19
IBEC has signed the European Commission Manifesto for maximizing the accessibility of research results in the fight against COVID19
.
IBEC participates in a roundtable on international collaboration in biotechnology
The Institute for Bioengineering of Catalonia participates in a roundtable on international collaboration in the field of biotechnology, as one of the main players in research and innovation applied to health.
Bioengineering to fight Covid-19
Yesterday took place the kick-off meeting of the european project MAD-CoV 2, in which participates the group led by ICREA Research Professor Núria Montserrat at IBEC.
Under the name of “Modern approaches for developing antivirals against SARS-CoV 2” (MAD-CoV 2) the project focuses on the development and delivery of therapeutic tools for the current COVID-19 outbreak.
IBEC alumni Riccardo Levato, awarded with an ERC starting grant
Since its foundation in 2006, IBEC has been growing and consolidating as a leading research center. This has only been possible thanks to the work, talent, commitment and motivation of each and every one of the people who are and have been part of IBEC’s big family.
Now, Riccardo Levato, former researcher at IBEC, has been awarded with an ERC starting grant at UMC Utrecht to develop his project named “VOLUME-BIO”.
Back to school, back to the lab!
The holidays are over and it’s time to go back to work, also for our youngest and curious minds of the students that visit us every year. Despite the situation we are experiencing due to the coronavirus outbreak, at the Institute for Bioengineering of Catalonia (IBEC) we are making an effort to resume some of our outreach activities in person.
In this sense, the IBEC laboratories have reopened the doors for the students participating in the “Bojos per la Bioenginyeria” and the “Batx2Lab” programs, adapting to this “new normality”.